Chemokine and Orphan Receptors in HIV-2 and SIV Tropism and Pathogenesis  by Edinger, Aimee L. et al.
t
a
c
o
m
i
h
e
a
e
i
e
e
N
n
a
N
1
n
S
t
t
n
k
S
1
e
I
f
A
m
t
m
P
C
E
Virology 260, 211–221 (1999)
Article ID viro.1999.9819, available online at http://www.idealibrary.com onMINIREVIEW
Chemokine and Orphan Receptors in HIV-2 and SIV Tropism and Pathogenesis
Aimee L. Edinger,* Janice E. Clements,† and Robert W. Doms*,1
*Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104; and †Division of Comparative
Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland 21205Received March 18, 1999; returned to author for revision May 2, 1999; accepted May 20, 1999
i
f
p
a
H
a
o
(
t
v
M
o
c
C
1
s
e
P
n
r
(
H
o
g
t
r
p
a
l
t
d
C
s
c
AHIV-1, HIV-2, and SIV are closely related lentiviruses
hat cause AIDS in certain primate hosts. Although HIV-1
nd HIV-2 both cause disease in humans, HIV-2 is more
losely related to SIV than to HIV-1. In fact, some isolates
f HIV-2 are more similar to SIV isolated from sooty
angabeys than to other HIV-2 strains, supporting the
dea that HIV-2 arose from the introduction of SIV into the
uman population in West Africa (Gao et al., 1992; Hirsch
t al., 1989). Because HIV-2 infection is characterized by
longer asymptomatic stage, slower progression to dis-
ase, and lower levels of transmission relative to HIV-1, it
s considered to be less pathogenic (reviewed in DeCock
t al., 1993; Markovitz, 1993; Marlink, 1996). With rare
xceptions (Livartowski et al., 1992; Locher et al., 1998;
ovembre et al., 1997), HIV does not cause disease in
onhuman primates although several monkey species
re infectable (Franchini et al., 1990; Kraus et al., 1998;
aidu et al., 1988; Otten et al., 1994; Stahl-Hennig et al.,
990; Zhang et al., 1994). Likewise, many species of
onhuman primates in Africa are naturally infected with
IV with active viral replication and viral loads as high as
hose seen in asymptomatic, HIV-positive humans (Har-
ung et al., 1992; Rey-Cuille´ et al., 1998). However, these
aturally infected monkey species (African green mon-
eys (AGMs) and sooty mangabeys) do not develop an
IV-induced immunosuppressive disease (Allan et al.,
991; Bibollet-Ruche et al., 1997; Desrosiers, 1990; Fultz
t al., 1986; Muller et al., 1993; Murphey-Corb et al., 1986).
n contrast, when SIV isolated from these naturally in-
ected African species is introduced into susceptible
sian species such as cynomologous monkeys, pigtail
acaques, or rhesus macaques, it induces a disease
hat closely parallels AIDS in humans in a period of
onths to 2–3 years, providing a useful model for HIV
1 To whom reprint requests should be addressed at Department of
athology, University of Pennsylvania, 806 Abramson, 34th Street and
ivic Center Boulevard, Philadelphia, PA 19104. Fax: (215) 573-2883.s-mail: doms@mail.med.upenn.edu.
211nfection and pathogenesis. SIV has also been isolated
rom mandrills, Sykes monkeys, L’hoest monkeys, chim-
anzees, and red capped mangabeys, and isolates usu-
lly bear the name of their species of origin (reviewed in
irsch and Johnson, 1994; Marx and Chen, 1998; see
lso Hirsch et al., 1999).
Early work in which CD4 was introduced into a variety
f nonprimate cell lines (and some human cell lines
Chesebro et al., 1990)) suggested that the primate len-
iviruses require a coreceptor along with CD4 to mediate
iral entry (Ashorn et al., 1990; Clapham et al., 1991;
addon et al., 1986; McKnight et al., 1994). On the heels
f the discovery that chemokine receptors function as
oreceptors for HIV-1 (reviewed in Berger, 1997;
lapham, 1997; Doms and Peiper, 1997; Moore et al.,
997), HIV-2 and SIV were reported to use some of the
ame molecules for viral entry (Chen et al., 1997; Edinger
t al., 1997a; Endres et al., 1996; Marcon et al., 1997;
leskoff et al., 1997). Subsequent work has identified
ovel coreceptor molecules that function as efficent co-
eceptors for SIV and HIV-2, but only rarely for HIV-1
Deng et al., 1997; Farzan et al., 1997).
This review will summarize (1) current knowledge of
IV-2 and SIV coreceptor usage patterns, (2) the impact
f chemokine receptor use on viral tropism and patho-
enesis, (3) the expression patterns of chemokine recep-
ors in nonhuman primates, (4) the ability of chemokine
eceptors to serve as primary receptors for CD4-inde-
endent entry, and (5) the interactions between HIV-2
nd SIV Envs and their coreceptor molecules on a mo-
ecular level.
CD4 is necessary but not sufficient for HIV-1 entry, and
hus coreceptors were hypothesized long before their
iscovery. In 1996, the chemokine receptors CCR5 and
XCR4 were identified as the major HIV-1 coreceptors,
purring intense investigation into the role these mole-
ules play in HIV infection and in the development of
IDS. These studies have greatly advanced our under-
tanding of HIV-1 pathogenesis, as coreceptor use im-
0042-6822/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.
p
d
t
d
(
e
v
w
c
T
v
a
f
1
m
s
s
l
m
1
o
e
h
u
r
t
m
u
m
p
t
r
i
c
c
b
c
U
e
C
(
1
n
b
i
c
t
l
i
p
t
1
w
t
t
p
t
i
t
p
e
t
c
C
p
c
o
t
v
a
H
t
c
s
1
f
f
D
C
p
t
n
r
a
i
t
u
d
a
g
t
i
m
H
o
r
p
i
t
p
t
c
A
(
k
p
212 MINIREVIEWacts HIV-1 tropism, transmission, and progression to
isease. The chemokine receptors CCR5 and CXCR4 are
he major HIV coreceptors, and all HIV strains studied to
ate use one or both of these molecules for viral entry
Doms et al., 1999). The use of CXCR4 and CCR5 largely
xplains in vitro cell tropism for HIV-1 isolates.
Viruses that use CCR5 as a coreceptor (designated R5
iruses) infect both primary T-cells and macrophages,
hile few transformed T-cell lines are susceptible. In
ontrast, CXCR4 (X4) strains replicate in a range of CD41
-cell lines as well as primary T-cells. Dual-tropic R5X4
iruses will replicate in transformed T-cell lines and can
lso infect macrophages by using either CCR5 or CXCR4
or entry (Rana et al., 1997; Simmons et al., 1998; Yi et al.,
998). The extent to which primary X4 isolates can infect
acrophages through CXCR4 is highly contentious, with
ome studies suggesting that all or most primary X4
trains infect macrophages, while other reports show
ittle or no infection by particular X4 viruses (Schmidt-
ayerova et al., 1998; Simmons et al., 1996, 1998; Yi et al.,
998). Contradictory reports may reflect different meth-
ds of macrophage culture and different levels of CXCR4
xpression. It seems clear, however, that X4 strains that
ave been passaged extensively through T-cell lines
sually replicate inefficiently in macrophages, likely as a
esult of both Env defects (Freed et al., 1995) and restric-
ions at postentry steps such as nuclear import (Schmidt-
ayerova et al., 1998). Nearly all in vitro studies have
sed macrophages derived from blood monocytes, a
acrophage model unlikely to represent all macrophage
opulations in vivo, and at least one study suggests that
here are differences in postentry events in blood-de-
ived macrophages and alveolar macrophages that could
nfluence the ability of X4 viruses to replicate in these
ells (Huang et al., 1993). The extent to which X4 strains
olonize macrophages in vivo is unknown.
Finally, a large number of alternative coreceptors have
een identified that support virus infection in vitro, in-
luding CCR2b, CCR3, CCR8, CCR9, GPR15, STRL33,
S28, CX3CR1 (formerly V28), APJ, and ChemR23. Gen-
rally, these receptors are used inefficiently relative to
CR5 or CXCR4, and their in vivo relevance is uncertain
Edinger et al., 1998a,b; Michael et al., 1998; Zhang et al.,
998). Potentially, acquisition of the ability to use alter-
ative coreceptors by HIV could broaden viral tropism,
ut thus far use of alternative coreceptors by HIV to
nfect primary cells has not been demonstrated.
In addition to having a large impact on tropism, core-
eptor use also plays a role in viral transmission. Indeed,
he critical role of CCR5 in HIV-1 transmission is high-
ighted by the high level of resistance to infection exhib-
ted by individuals who are homozygous for a 32-base-
air deletion (D32/D32 individuals) in CCR5 that renders
hem CCR5-negative (Dean et al., 1996; Huang et al.,
996; Liu et al., 1996; Samson et al., 1996). Consistent
ith this are previous observations that R5 viruses are mhe predominant phenotype present early in HIV-1 infec-
ion (Connor et al., 1997). Coreceptor use may also im-
act disease progression. The appearance of viruses
hat can use CXCR4 correlates with progression to AIDS
n roughly 30% of patients and virus isolated from symp-
omatic individuals can display a broader coreceptor use
attern than that from asymptomatic individuals (Connor
t al., 1997). Whether the ability to use coreceptors other
han CCR5 results in progression to disease or is merely
orrelated with this event is not known.
Like HIV-1, all HIV-2 isolates examined thus far use
CR5, CXCR4, or both molecules as coreceptors in the
resence of CD4 (for a table summarizing HIV-2 core-
eptor use, see Doms et al., 1999). In most cases, CCR5
r CXCR4 is the most efficient coreceptor for HIV-2,
hough some viral isolates use alternative coreceptors
ery efficiently in vitro (Guillon et al., 1998; McKnight et
l., 1998; Owen et al., 1998). The relationship between
IV-2 coreceptor use and macrophage tropism is uncer-
ain. However, a correlation between disease state and
oreceptor use similar to that observed in HIV-1 infection
eems to exist for HIV-2 (Chen et al., 1998a; Guillon et al.,
998; Owen et al., 1998; Sol et al., 1997). HIV-2 isolates
rom asymptomatic patients generally use CCR5 and
requently cannot replicate in PBMCs isolated from D32/
32 individuals, while strains that predominantly use
XCR4 have been isolated from symptomatic and AIDS
atients (Reeves and Clapham, personal communica-
ion). Most HIV-2 isolates, however, tend to use a larger
umber of coreceptors in vitro including some used
arely or not at all by HIV-1 (Chen et al., 1998a; Owen et
l., 1998; Sol et al., 1997, 1998). Unlike HIV-1, some HIV-2
solates can use alternative coreceptors for efficient en-
ry into primary cells as several HIV-2 strains that do not
se CXCR4 have been shown to replicate in CCR5-
eficient human PBMCs (Chen et al., 1997, 1998a; Sol et
l., 1997). It is interesting to note that, while HIV-2 is
enerally promiscuous in its coreceptor use, a pheno-
ype correlated with progression to disease in HIV-1
nfection, HIV-2 appears to be less pathogenic than the
ore fastidious HIV-1.
SIV tropism differs significantly from that defined for
IV-1. Virtually all SIV isolates are able to replicate in one
r more T-cell lines and in PBMCs. Viruses that can also
eplicate in macrophages earn the designation macro-
hage-tropic (M-tropic, Fig. 1). Thus, an SIV isolate des-
gnated as M-tropic is usually better described as dual-
ropic. It is important to realize that SIV is frequently
assaged on human PBMCs or T-cell lines during isola-
ion, and the virus isolation protocol used may signifi-
antly affect the coreceptor use of the isolates obtained.
lthough SIV tropism appears to map largely to Env
Banapour et al., 1991a,b; Flaherty et al., 1997; Man-
owski et al., 1997; Mori et al., 1993), it is clear that the
attern of coreceptor use alone does not determine SIV
acrophage tropism. Unlike HIV, all SIV isolates identi-
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213MINIREVIEWied to date (with two exceptions) efficiently use CCR5 as
coreceptor (see Doms et al., 1999, for a complete
ummary of SIV coreceptor use). Despite this nearly
niversal ability to use CCR5, not all SIVs are M-tropic.
owever, coreceptor use may still impact SIV macro-
hage tropism. The SIVmac239 molecular clone is the
est characterized example of a T-tropic SIV. The failure
f SIVmac239 to replicate efficiently in macrophages is
etermined by envelope sequences (Anderson et al.,
993; Banapour et al., 1991a; Chen et al., 1997; Flaherty et
l., 1997; Mori et al., 1993) despite the fact that the
IVmac239 Env supports entry into these cells (Mori et
l., 1993). Interestingly, SIVmac239 and its M-tropic vari-
nt, SIVmac316, interact with chimeras made between
CR5 and CCR2b differently in cell–cell fusion assays
Edinger et al., 1997a) and gp120 from the the M-tropic
IVsmPBj1.9 but not SIVmac239 causes intracellular cal-
ium release and chemotaxis in primary cells (Weissman
t al., 1997). Thus, it may be that Env-mediated signaling
hrough G proteins normally coupled to CCR5 activates
he macrophage and creates a more permissive environ-
ent for viral replication; M-tropic viruses may interact
ith CCR5 in a manner that induces signaling through
CR5 while T-tropic viruses do not. The HIV-2 clone
K7312A uses CCR5 as a coreceptor but does not repli-
ate in macrophages and may therefore represent an
IV-2 with a phenotype similar to that of SIVmac239 (Hill
t al., 1997).
It is also possible that use of coreceptors other than
CR5 impacts SIV macrophage tropism. The orphan re-
eptors GPR1, GPR15/BOB, and STRL33/BONZO were
FIG. 1. SIV macrophage tropism. M-tropic (M) SIV can replicate
fficiently in macrophages, primary CD4-positive T-cells, and usually in
ne or more of a variety of T-cell lines. T-tropic (T) SIV replicates
fficiently in primary CD4-positive T-cells and in T-cell lines, but not in
acrophages. As T-tropic SIVs can use CCR5 as a coreceptor, it is not
lear why these viruses do not replicate well in macrophages, but the
lock to replication appears to occur postentry.dentified in 1997 as the coreceptors responsible for SIV ontry into the many CCR5-negative T-cell lines that sup-
ort high levels of viral replication (Deng et al., 1997;
arzan et al., 1997). SIV isolates presumably use one or
ore of these orphan receptors as coreceptors in human
BMCs isolated from D32/D32 individuals (Chen et al.,
997, 1998a), suggesting that at least some of these
olecules are expressed on primary cells at levels suf-
icient to support viral entry. However, the ability to use
PR1, GPR15, and STRL33 as coreceptors is unlikely to
ccount for the replication of some but not other SIVs in
acrophages. SIVmac239 can use all three of these
oreceptors while the M-tropic isolate SIVsm62D (Hirsch
t al., 1994) cannot use any for entry into transfected
93T cells (Deng et al., 1997; Edinger et al., 1998a; Farzan
t al., 1997). However, GPR1, which may be differentially
xpressed on alveolar macrophages (Edinger et al.,
998b; Farzan et al., 1997), may influence pathogenesis
s certain SIV strains replicate in the alveolar macro-
hages of macaques with SIV-induced pneumonia (Man-
owski et al., 1998). The use of other orphan receptors
ay also influence tissue tropism. Both ChemR23 and
PJ can serve as coreceptors for some isolates.
hemR23 is found on dendritic cells and may participate
n infection of these cells by certain SIV strains (Samson
t al., 1998). APJ mRNA is detectable in a variety of CNS
ell types, and it is possible that APJ has a role in
europathogenesis, perhaps through interactions with
p120 shed from virions and infected cells (Choe et al.,
998; Edinger et al., 1998b). Such a mechanism may be
articularly important in the degeneration and loss of
eurons as this cell type is not itself infected. Finally, it is
lso possible that cell-type-specific, posttranslational
odification of chemokine or orphan receptors may in-
luence the ability of a virus to use a given coreceptor in
particular cell type (Farzan et al., 1999).
It is also interesting to consider the list of coreceptors
hat SIV cannot use. Only one uncloned SIV strain,
IVmnd(GB-1), can use CXCR4 as a coreceptor (Schols
nd de Clercq, 1998), despite the observations that many
losely related HIV-2 isolates efficiently use CXCR4 for
ntry, CXCR4 cloned from rhesus monkeys is functional
or X4 HIV-1s (Chen et al., 1997, 1998a; Edinger et al.,
997a), and a molecularly cloned SHIV that uses only
XCR4 is pathogenic in rhesus macaques (Hoffman et
l., 1998; Liu et al., 1999). Another commonly used HIV
oreceptor that does not function for any SIV isolate is
CR3. Rhesus CCR3 is more divergent from the human
omolog than are rhesus CCR5 and CXCR4; human
CR3 is more negatively charged in the N-terminus,
hich is intriguing given the role charge–charge interac-
ions are thought to play in coreceptor binding (Sol et al.,
998). As mentioned above, two SIV isolates do not use
CR5, SIVmnd(GB-1) (Schols and de Clercq, 1998) and
IVrcmGab-1, which was isolated from a red capped
angabey (SIVrcm also has the distinction of being thenly SIV known to use CCR2b) (Chen et al., 1998b).
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214 MINIREVIEWt is unclear whether SIVmnd(GB-1) is unable to use
hesus or mandrill CCR5 or whether SIVmnd(GB-1) and
IVrcmGab-1 are macrophage-tropic. For most of the
IVs tested so far, human and rhesus CCR5 are equally
fficient coreceptors for entry, but it is not clear whether
pecies-specific sequence differences will be important
or some isolates, particularly as there is evidence that
uman CCR5 is a less efficient primary receptor than the
hesus homolog (Edinger et al., 1999). For the limited
trains tested, rhesus and human CD4 appear to function
qually well (Chen et al., 1997).
Relatively little is known about CCR5 expression in
onhuman primates, although it is clear that large in-
reases in CCR5 expression levels accompany lympho-
yte activation (Rottman et al., 1997). Message for an-
ther SIV coreceptor, STRL33, has been detected by
T-PCR in rhesus PBMCs (Edinger et al., 1997b). Other
han these studies, little has been done to confirm that
xpression of other coreceptors in simian hematopoetic
ells mirrors that in human cells. Chemokine receptor
xpression in the CNS of macaques has been more
horoughly evaluated. Using immunohistochemistry, Rott-
an et al. (1997) found that macaque CNS endothelium,
ascular smooth muscle, astrocytes, neurons of the ce-
ebrum and hippocampus, and CD681 cells morpholog-
cally consistent with microglia were diffusely positive for
CR5. Another study by Westmoreland et al. (1998) ob-
erved CCR5 staining in macaque glial cells morpholog-
cally consistent with microglia, astrocytes, and pyrami-
al neurons by immunohistochemistry. Rhesus brain-
erived endothelial cells (BCECs) express both CCR5
nd STRL33 by RT-PCR (Edinger et al., 1997b). The ex-
ression of these coreceptors in the CNS may impact
IV-induced neuropathogenesis both by allowing viral
nfection and through the possible effects of shed gp120
r virion-associated Env binding to these molecules.
A human allele encoding a prematurely truncated form
f CCR5 (D32) that is not expressed on the cell surface is
significant, though surmountable, barrier to infection
ith HIV-1 in homozygous individuals (Dean et al., 1996;
uang et al., 1996; Liu et al., 1996; Samson et al., 1996)
nd is associated with delayed disease progression in
eterozygotes (Dean et al., 1996; Michael et al., 1997). It
s intriguing that a similar mutation has been reported in
ooty mangabeys and in red capped mangabeys (rcms)
Chen et al., 1998b; Palacios et al., 1998). This mutant
angabey CCR5 allele contains a 24-basepair deletion
n the fourth transmembrane region, which abrogates
urface expression (Palacios et al., 1998). The allele
requency in sooty mangabeys is 4%, and no homozy-
otes have been identified (Chen et al., 1998b; Palacios
t al., 1998). However, red capped mangabeys have a
uch higher allele frequency (87%) and many homozy-
ous individuals have been reported; the R2b-tropic iso-
ate SIVrcmGab-1, which does not use CCR5 as a core-
eptor, was isolated from a rcm D24 homozygote (Chen mt al., 1998b). None of the other 13 rcms examined by
hen et al. (1998b) was infected with SIV, but sooty
angabeys heterozygous for the D24 mutation can be
nfected with SIV and no large differences in viral load
ere detected despite the decreased expression (2.4-
old less) of CCR5 on the cells of heterozygotes (Palacios
t al., 1998). This deletion in CCR5 may have provided a
elective advantage for these animals in resisting infec-
ion with a particular pathogen or a highly pathogenic
train of SIV. It will be interesting to determine whether
ther monkey populations carry similar deletions and
hether D24 homozygotes can be infected with SIV iso-
ates that use coreceptors other than CCR5 and CCR2b.
The first report of a CD4-independent primate lentivi-
us occurred in 1992 when ROD/B, a tissue culture pas-
aged version of HIV-2 ROD/A, was shown to efficiently
nfect the CD4-negative human cell line RD (a rhabdo-
yosarcoma cell line) (Clapham et al., 1992). The discov-
ry that chemokine receptors are HIV coreceptors made
hese molecules logical candidates for the primary re-
eptor for CD4-independent infection. It was quickly
hown that both ROD/B and another laboratory-adapted
IV-2 strain (VCP) use CXCR4 for entry in the absence of
D4 (Endres et al., 1996; Reeves et al., 1997). Importantly,
D4-independent infection by HIV-2 is not restricted to
ab-adapted isolates. A primary HIV-2 isolate, 2A195811,
s capable of using rhesus CCR5 as a primary receptor
Chen et al., 1998a), while a larger study showed that
ine primary R5 and X4 HIV-2 isolates infected CD4-
egative cell lines expressing CCR5 or CXCR4, respec-
ively (Jackie Reeves and Paul Clapham, personal com-
unication). The levels of CD4-independent infection
etected with these primary HIV-2s were significantly
igher than those observed with a similar panel of pri-
ary HIV-1 isolates. Interestingly, primary R5X4 HIV-2
trains could not use both CCR5 and CXCR4 CD4 inde-
endently. These isolates used either CCR5 or CXCR4 as
primary receptor or were completely CD4-dependent
Jackie Reeves and Paul Clapham, personal communica-
ion).
CD4-independent infection is not restricted to HIV-2.
IV/17E-Fr enters primary rhesus BCECs CD4-indepen-
ently (Mankowski et al., 1994) by using CCR5 as a
rimary receptor (Edinger et al., 1997b). Many other CD4-
ndependent SIV isolates have also been described
Edinger et al., 1997b). Interestingly, when rhesus rather
han human CCR5 is provided as a primary receptor,
ven a larger number of SIVs are capable of CD4-inde-
endent infection, though with varying degrees of effi-
iency (Chen et al., 1998a; Edinger et al., 1997b, 1999).
trictly CD4-dependent SIV strains have also been de-
cribed, notably SIVmac239. Some SIV and HIV-2 iso-
ates display an intermediate phenotype. These viruses
re not capable of CD4-independent infection, but can
nter cells if soluble CD4 (sCD4) is included in the
edium, a treatment that blocks infection by many HIV-
1
n
s
e
(
C
i
t
u
p
a
s
l
i
a
t
w
f
i
t
c
o
d
c
i
p
1
r
i
m
p
o
t
u
t
o
1
C
t
g
o
p
y
l
(
s
C
c
p
c
a
b
d
1
m
W
i
n
n
a
p
T
c
s
e
b
a
p
t
i
i
a
c
u
c
o
c d viral
215MINIREVIEWs. For example, the two SIVagm Envs tested so far are
ot capable of mediating CD4-independent cell–cell fu-
ion (Edinger et al., 1997b); however, sCD4 treatment can
nhance infection by at least some SIVagm isolates
Allan et al., 1990; Werner et al., 1990). Thus far, only
XCR4 and CCR5 have been shown to support CD4-
ndependent infection by HIV-2 and SIV. Efficient infec-
ion by ROD/B through CX3CR1 and CCR3 requires sol-
ble CD4 (sCD4) and is therefore not totally CD4-inde-
endent (Reeves et al., 1997) and infection in the
bsence of membrane-bound CD4 has not been ob-
erved for GPR15 or STRL33 even in the presence of high
evels of sCD4 (Edinger et al., 1997b, 1999). The CD4-
ndependent infection observed with a variety of HIV-2
nd SIV strains but not HIV-1 may reflect a “partially
riggered” native Env conformation for HIV-2 and SIV in
hich the coreceptor binding site is at least partially
ormed and exposed prior to conformational changes
nduced by CD4 binding.
The CD4-independent phenotype could influence viral
ropism and pathogenesis by enabling virus to infect
ertain CD4-negative cells, by enabling efficient infection
f cells expressing low levels of CD4, and by allowing
irect Env–coreceptor interactions that could impact
hemokine receptor function. For instance, the ability to
nfect BCECs may influence neurotropism and neuro-
athogenesis (Edinger et al., 1997b; Mankowski et al.,
994, 1997). Although perivascular macrophages are cur-
ently believed to carry virus into the CNS, viruses infect-
ng BCECs would not only be able to seed the CNS, but
ay derange normal BCEC function, resulting in a com-
romised blood–brain barrier that could allow the entry
f both SIV and opportunistic pathogens. The observa-
ion that SIV can infect transformed B-cells in vitro (J.E.C.,
npublished observations) suggests a possible role for
hese viruses in SIV-associated B-cell lymphomas, some
f which are EBV-negative (reviewed in Desrosiers,
990), either by direct infection or by binding of Env to
FIG. 2. Model for Env-mediated, CD4-dependent membrane fusion. (A
onformational changes in Env, likely including a shift in the position of t
f a conserved chemokine receptor binding site in gp120, which then
hemokine receptor binding that results in fusion peptide exposure anCR5, which could potentially result in signal transduc- Hion. Recent studies have found SIV associated with the
lomerulus in macaques with renal pathology; infection
f kidney cells would likely require a CD4-independent
athway for entry (Stephens et al., 1998).
CD4 independence may also have ramifications be-
ond tropism. CD4-independent viruses can down-regu-
ate chemokine receptor expression in infected cells
Endres et al., 1996), perhaps providing an additional
uperinfection exclusion mechanism. Direct binding of
D4-independent Envs to coreceptors could induce re-
eptor signaling. It is not yet known whether CD4-inde-
endent SIVs down-modulate CCR5, but shed gp120 is
learly competent to bind CCR5 without CD4 (Edinger et
l., 1999; Martin et al., 1997) and SIVmac251 gp120 has
een shown to induce both a Ca21 flux and neuronal cell
eath in primary rat hippocampal cultures (Meucci et al.,
998). Finally, it is also possible that CD4 independence
ay actually result in a virus that is less pathogenic.
hen an uncloned SIVmac251 stock capable of CD4-
ndependent infection in vitro was inoculated intravagi-
ally into a rhesus macaque, viruses isolated at eutha-
asia due to clinical AIDS were CD4-dependent (Chen et
l., 1998a), suggesting that the acquisition of CD4 de-
endence accompanied the development of disease.
his is consistent with the hypotheses that high-affinity
ell surface binding through CD4 would enhance viral
pread and that CD4-dependent viruses would better
vade antibodies to the conserved chemokine receptor
inding site in Env. In summary, there are multiple mech-
nisms by which CD4 independence may influence tro-
ism and pathogenesis that await experimental verifica-
ion.
CD4-dependent infection is thought to begin with the
nduction of conformational changes in Env by CD4 bind-
ng. These changes render Env competent to bind an
ppropriate coreceptor, which in turn results in further
onformational changes that expose the fusion peptide,
ltimately resulting in membrane fusion (Fig. 2). For
ntry process begins with CD4 binding to Env, (B) CD4 binding triggers
nd V1/V2 loops, which are believed to result in the increased exposure
to CCR5; (C) a second conformational change in Env is induced by
and cellular membrane fusion.) The e
he V3 a
bindsIV-1, the domains of Env that directly contact CD4 and
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216 MINIREVIEWhe coreceptor are partially defined. The V3 loop is
hought to be involved in coreceptor binding based on
he results of Env binding studies using anti-V3 antibod-
es and Env mutants with V3 loop deletions (Trkola et al.,
996; Wu et al., 1996). Changes in the position of the
1/V2 and V3 loops are hypothesized to increase the
xposure of a highly conserved chemokine receptor
inding site that lies between these loops in the HIV-1
IIB crystal structure (Rizzuto et al., 1998). Interactions
etween this site and the coreceptor may induce the
onformational changes in Env that lead to membrane
usion.
In contrast with HIV-1, much less is known about the
eterminants in SIV Env that are responsible for core-
eptor choice and for the interactions that lead to mem-
rane fusion. For example, the role of the SIV V3 loop in
ntry is not yet clear. There are multiple reports that the
3 loop of SIV is not as variable as that of HIV-1 (Burns
nd Desrosiers, 1991; Overbaugh et al., 1991), but the use
f CCR5 by virtually all SIV isolates may help explain this
bservation. Nonetheless, mutations within the SIV-
ac239 V3 loop can affect macrophage and cell line
ropism (Kirchhoff et al., 1994; Mori et al., 1993), and
ignificant variation in V3 sequences has been docu-
ented in viruses isolated from different tissues in ma-
aques with SIVmac316-induced AIDS (Kodama et al.,
993). However, these changes have not yet been linked
o differential use of coreceptors. Other regions in SIV
nv may also be involved in determining coreceptor use.
everal papers have identified V1 and to a lesser extent
4 as the most variable regions of SIV Env (Hirsch et al.,
994; Overbaugh et al., 1991). It remains unclear whether
ariability in these regions reflects escape from immune
urveillance or the ability to use different combinations
f chemokine receptors or both. For HIV-2, indirect evi-
ence suggests that the V3 loop is important for core-
eptor use as conversion from a slow/low (generally
ssociated with an R5 phenotype for HIV-1) to rapid/high
generally X4 viruses) phenotype in an infected patient is
FIG. 3. Rhesus CCR5 extracellular domains. Residues in rhesus CCR
nverse shaded. The second extracellular loop is shaded gray due to i
re involved have not been finely mapped. The aspartic acid at position
s rhesus is a proline in sooty mangabey CCR5.ssociated with an increase in positive charge in the V3 roop (Albert et al., 1996). Importantly, many of the resi-
ues identified in HIV-1 that comprise the coreceptor
inding site in the bridging sheet of gp120 are conserved
etween HIV-1, HIV-2, and SIV. Thus, this region may play
n important role in Env–coreceptor interactions for
hese viruses as well as for HIV-1. Further mutational
nalysis will be required to more finely map the residues
n SIV and HIV-2 Env that directly interact with chemokine
eceptors.
Much more is known about the domains in CCR5 that
re important for SIV coreceptor function. Studies using
himeras between human CCR5 and CCR2b (Edinger et
l., 1997a) or NIH Swiss mouse CCR5 (Kuhmann et al.,
997) have identified the second extracellular loop of
CR5 as necessary and sufficient for SIV coreceptor
ctivity in the context of these chimeras and have shown
hat the addition of the N-terminus enhances the inter-
ction. Although the CCR5 N-terminus is clearly not re-
uired in the presence of CD4, truncating the N-terminus
esults in progressively less efficient infection by SIV
Edinger et al., 1999; Hill et al., 1998; Kuhmann et al.,
997). Studies evaluating homologs and point mutants
ave identified specific residues in CCR5 that may con-
act SIV Env. Kuhmann et al. (1997) found that an AGM
CR5 allele containing a Y14N change in the N-terminus
as a less efficient coreceptor than a clone that did not
ontain this change, consistent with an earlier study
dentifying Y10, D11, and Y14 as important for SIVmac239
uciferase virus entry (Farzan et al., 1998). Thus, multiple
yrosine residues in the CCR5 N-terminus have been
stablished as important for interactions with SIV Env
Fig. 3). It has been suggested that a YXXXYY motif
resent in CCR5, GPR1, and GPR15 (the motif could be
XXXY in STRL33 and Chem R23) is critical for corecep-
or function (Farzan et al., 1998). There is also a NYYG
equence in the APJ N-terminus that resembles the
YYT found in CCR5 (Choe et al., 1998; Edinger et al.,
998b).
CD4-independent viruses have also helped identify
ave been shown to play a role in Env-mediated membrane fusion are
ribed role in entry, although the specific residues in this domain that
hesus is an asparagine in human CCR5 and the serine at position 1805 that h
ts desc
13 in regions of CCR5 critical for Env binding. Chimeras be-
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217MINIREVIEWween CCR5 and CCR2b that lack the CCR5 N-terminus
o not function as primary receptors in the absence of
D4 and generally cannot be rescued by the addition of
CD4 (Edinger et al., 1999), suggesting a deficit in Env
inding. N-terminal truncation mutants of CCR5 do not
upport binding of SIV gp120 and do not function as
oreceptors in the absence of CD4. A particularly impor-
ant residue in the CCR5 N-terminus is at position 13,
hich is polymorphic between humans and rhesus ma-
aques. Interestingly, while rhesus and human CCR5
upport SIV infection equally well in the presence of
D4, rhesus CCR5 supports CD4-independent SIV infec-
ion more efficiently and for a larger number of virus
trains than does human CCR5. This difference has been
apped to the N13D change between human and rhesus
CR5 (Edinger et al., 1999), consistent with the role this
esidue plays in direct Env binding in the absence of CD4
Edinger et al., 1999; Martin et al., 1997). Taken together,
hese studies indicate that the N-terminal domain of
CR5 plays an important role in Env binding. In the
bsence of CD4, this region is critical for primary recep-
or function. However, in the presence of CD4, mutations
n the N-terminal region of CCR5 are more readily toler-
ted, perhaps because CD4 provides the binding func-
ion in trans. In contrast, the second extracellular loop of
CR5 is critical for coreceptor function both in the pres-
nce and in the absence of CD4 and so may be involved
n interactions that lead directly to membrane fusion.
CD4-independent viruses have also helped identify a
ossible phenotype for the S180P change relative to the
hesus homolog present in sooty mangabey CCR5 (Chen
t al., 1998a; Palacios et al., 1998). When S180P is
resent in the background of human CCR5, CD4-inde-
endent infection is significantly decreased (Edinger et
l., 1999). Even more striking is the complete loss of
IV/17E-Fr CD4 independence when the AGM CCR5
llele containing a N13D change is provided as a primary
eceptor despite efficient function of this molecule as a
oreceptor in the presence of CD4 (Edinger et al., 1999;
uhmann et al., 1997; Kunstman et al., manuscript in
reparation). These findings are particularly intriguing as
oth sooty mangabeys and African green monkeys are
hronically infected with SIV in the wild without ever
eveloping an SIV-induced immunodeficiency disease
reviewed in Desrosiers, 1990). It is tempting to hypoth-
size that coevolution of the virus and host has occurred
n these species that has limited the pathogenesis of SIV
nd the efficiency of Env interactions with CCR5.
The discovery of HIV-2 and SIV coreceptors has al-
owed significant advances in the area of viral entry.
IV-2 and SIV display a much broader coreceptor use
attern than HIV-1, in several cases using coreceptors
hat HIV-1 typically cannot. The relationship between
oreceptor use and tropism remains to be clarified for
IV-2, but SIV plainly defies the X4/R5 designations usedo describe HIV-1 tropism as both T- and M-tropic iso-ates use CCR5 as a coreceptor. Tissue-specific local-
zations of coreceptors may influence tissue tropism at
he level of entry. Interestingly, some HIV-2 and SIV iso-
ates can use chemokine receptors as primary receptors
n the absence of CD4. Such CD4-independent infection
ay have implications for tropism and pathogenesis and
ndicates that chemokine receptors were the original
rimate lentiviral receptor, with CD4 representing a co-
eceptor acquired to enhance infection efficiency, per-
aps by allowing better evasion of the immune system.
n fact, a CD4-independent HIV-1 strain in which the
oreceptor binding site is stably exposed exhibits a neu-
ralization-sensitive phenotype (Hoffman et al., 1999), and
he CD4-independent SIVmac17E/Fr is also more sensi-
ive to antibody-mediated neutralization than the CD4-
ependent SIVmac239. Thus, acquisition of the ability to
se CD4 may make it possible to shield the conserved
oreceptor binding site from neutralizing antibodies until
ust before virus infection.
The regions of HIV-2 and SIV Env that interact with
hemokine receptors are not yet clearly defined, but it is
ikely that the highly conserved residues identified in the
p120 crystal structure will be involved along with resi-
ues in the V1/V2 and V3 variable loops. Both tyrosine
nd aspartic acid residues in the N-terminus of CCR5 are
mportant for interaction with Env, and the acidic resi-
ues of the CCR5 N-terminus may bind to the highly
asic proposed chemokine receptor binding site in Env.
any questions remain unresolved. What is the impact
f chemokine receptor use on SIV in vivo tropism, patho-
enesis, and viral transmission? What role do the orphan
eceptors play in vivo in humans and macaques? Is
nv-mediated signaling important in some cell types and
ot others? How does CD4-independent infection impact
athogenesis and what cells are infected through this
athway in vivo? Why do sooty mangabeys and African
reen monkeys not progress to disease and do chemo-
ine receptors play a role in this protection? Hopefully
nswers to questions like these surrounding the HIV-2
nd SIV entry process will lead to more effective thera-
ies and prophylaxis for the future.
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